Author

Yuki Maruyama

Cleveland ClinicPrimary ORCID profile (0000-0002-0812-1478 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yuki MaruyamaiD1 paper · Shionogi (Japan)

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Daigo OkadaiD· 1 shared Danielle D. KishiD· 1 shared Hidetoshi TsudaiD· 1 shared Karen S. KeslariD· 1 shared Nina DvorinaiD· 1 shared Robert L. FairchildiD· 1 shared William M. BaldwiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Daigo OkadaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NK Cells Effectively Mediating Antibody-Mediated Kidney Allograft Rejection Requires a Specific Activation Receptor and Graft Expression of the Ligand

Yuki Maruyama, Daigo Okada, Hidetoshi Tsuda, Danielle D. Kish, Karen S. Keslar, Nina Dvorina, William M. Baldwin, Robert L. Fairchild

This study shows that NK cell activation via NKG2D and graft Rae-1e ligand is essential for antibody-mediated kidney allograft rejection, even with high DSA levels.

bioRxiv · Mar 5, 2026 · PreprintImmunology